Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 25;9(8):1069.
doi: 10.3390/nano9081069.

Carbon Nano-Onions as Non-Cytotoxic Carriers for Cellular Uptake of Glycopeptides and Proteins

Affiliations

Carbon Nano-Onions as Non-Cytotoxic Carriers for Cellular Uptake of Glycopeptides and Proteins

Marta d'Amora et al. Nanomaterials (Basel). .

Abstract

Carbon nano-onions (CNOs) possess favorable properties that make them suitable for biomedical applications, including their small size, ready surface modification, and good biocompatibility. Here, we report the covalent immobilization of a synthetic glycopeptide and the protein bovine serum albumin (BSA) onto the surface of carbon nano-onions using the maleimide-thiol "addition reaction". The glycopeptide and BSA are readily transported inside different cell lines, together with carbon nano-onions, through the endocytosis pathway. Our results show that carbon nano-onions are excellent scaffolds for glycopeptides and proteins immobilization and act as intracellular carriers for these biomolecules. These findings open new perspectives in the application of carbon nano-onions as intracellular transporters in diverse biomedical applications.

Keywords: biomedical applications; biomolecules; carbon nano-onions; carriers; scaffolds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Ligation reaction between synthetic glycopeptide 1 and maleimido decorated CNO (Mal-CNO).
Scheme 2
Scheme 2
Ligation reaction between BSA-FITC and Mal-CNO.
Figure 1
Figure 1
Characterization of the functionalized glycopeptide-CNO conjugate (Gly-CNO). (A) Thermogravimetric analysis of p-CNO (black), ox-CNO (blue), PEG-CNO (red), and Gly-CNO (green). All experiments were run in air with a temperature rate of 10 °C min−1. (B) Absorption spectra of Gly-CNO (solid line) and fluorescent labeled glycopeptide 1 (dotted line) in DMEM phenol red free at a concentration of 10 μg mL−1. (C) ATR-FTIR spectra of Gly-CNO using germanium crystals and 256 scans. (D) Emission spectra (λexc = 490 nm) of fluorescent labeled glycopeptide 1 (dotted line) and Gly-CNO (solid line) in DMEM at a concentration of 10 μg mL−1. (E) HR-TEM image of a portion of a cluster of Gly-CNOs, partly suspended on a hole in the carbon film.
Figure 2
Figure 2
Characterization of the functionalized bovine serum albumin (BSA)-CNO. (A) Thermogravimetric analysis of p-CNO (black), ox-CNO (blue), PEG-CNO (red), and BSA-CNO (green). All experiments were run in air with a temperature rate of 10 °C min−1. (B) Absorption spectra of BSA-CNO (solid line) and BSA-FITC (dotted line) in DMEM phenol red free at a concentration of 10 μg mL−1. (C) ATR-FTIR spectra of BSA-CNO using germanium crystals and 256 scans. (D) Emission spectra (λexc = 490 nm) of BSA-FITC (dotted line) and BSA-CNO (solid line) in DMEM at a concentration of 10 μg mL−1. (E) HR-TEM image of a portion of a cluster of BSA-CNOs, partly suspended on a hole in the carbon film.
Figure 3
Figure 3
Cellular viability of (a) NIH 3T3 and (b) MCF7 cells treated with different concentrations (10 and 20 µg mL−1) of ox-CNOs, Gly-CNOs, and BSA-CNOs for 24, 48, and 72 h, revealed by WST 1 assay. Viability (%) is evaluated for the samples of CNOs against a nontreated control (ctrl). Data are expressed as mean ± standard error as calculated from three separate experiments.
Figure 4
Figure 4
Cellular viability of (a) NIH 3T3 and (b) MCF7 cells treated with different concentrations (10 and 20 µg mL−1) of glycopeptide 1 and BSA-FITC for 24, 48, and 72 h, revealed by WST 1 assay. Viability (%) is evaluated for the samples of peptides against a nontreated control (ctrl). Data are expressed as mean ± standard error as calculated from three separate experiments.
Figure 5
Figure 5
Fluorescent images of 3T3 cells incubated with Gly-CNOs at a mass concentration of 20 µg mL−1 for 2, 6, 12, and 24 h. Nuclei are stained with Hoechst 33342 (blue). Scale bars = 20 µm.
Figure 6
Figure 6
Fluorescent images of 3T3 cells incubated with Gly-CNOs at a mass concentration of 10 µg mL−1 for 16 h. Scale bars = 20 µm.
Figure 7
Figure 7
Fluorescent images of 3T3 cells incubated with glycopeptide 1 at a mass concentration of 5 µg mL−1 for 2, 6, 12, and 24h. Nuclei are stained with Hoechst 33342 (blue). Scale bars = 20 µm.
Figure 8
Figure 8
Fluorescent images of 3T3 cells incubated with BSA-CNOs at a mass concentration of 1 µg mL−1 for 24 h. Nuclei are stained with Hoechst 33342 (blue). Scale bars = 25 µm.
Figure 9
Figure 9
Fluorescent images of MCF-7 cells incubated with BSA-CNOs at a mass concentration of 1 µg mL−1 for 24 h. Scale bars = 20 µm.
Figure 10
Figure 10
Fluorescent images of MCF-7 cells incubated with BSA-FITC at a mass concentration of 1 µg mL−1 for 24 h. Scale bars A–D = 20 µm.

References

    1. Bartelmess J., Quinn S.J., Giordani S. Carbon nanomaterials: Multi-functional agents for biomedical fluorescence and Raman imaging. Chem. Soc. Rev. 2015;44:4672–4698. doi: 10.1039/C4CS00306C. - DOI - PubMed
    1. Oliveira S.F., Bisker G., Bakh N.A., Gibbs S.L., Landry M.P., Strano M.S. Protein functionalized carbon nanomaterials for biomedical applications. Carbon. 2015;95:767–779. doi: 10.1016/j.carbon.2015.08.076. - DOI
    1. Liu Z., Robinson J.T., Tabakman S.M., Yang K., Dai H. Carbon materials for drug delivery & cancer therapy. Mater. Today. 2011;14:316–323.
    1. Zhang R., Olin H. Carbon nanomaterials as drug carriers: Real time drug release investigation. Mater. Sci. Eng. C. 2012;32:1247–1252. doi: 10.1016/j.msec.2012.03.016. - DOI
    1. Amora M., Giordani S. Smart Nanoparticles for Biomedicine. Elsevier; Amsterdam, The Netherlands: 2018. Carbon Nanomaterials for Nanomedicine; pp. 103–113.

LinkOut - more resources